FDA's Pediatric Advisory Committee (PAC) advises the agency on pediatric regulatory issues — drug and device safety questions specific to children — and its next public meeting runs , 10 a.m.–4 p.m. ET, held virtually and open to the public.

Dates and format

  • Date: 16 September 2026, 10 a.m.–4 p.m. ET
  • Format: fully virtual, open to the public, via online teleconferencing/video conferencing
  • Docket: FDA-2026-N-7514, established for public comment per the Federal Register notice
  • Organizer: FDA's Pediatric Advisory Committee

What it covers

The Pediatric Advisory Committee reviews pediatric-specific safety and regulatory questions across FDA's drug and device portfolios — the body that exists because a therapy's adult profile does not automatically answer how it behaves in children. FDA's Federal Register notice establishing this meeting's docket had not yet published a topic-level agenda as of this listing's verification date; check the notice directly closer to the date for the specific matters on the table.

Who should attend

Regulatory affairs and clinical professionals working on pediatric drug or device development, safety leads tracking FDA advisory-committee activity relevant to their programs, and anyone who wants to submit public comment through the meeting's docket. The meeting is open to the public and free to watch.

Working a webinar into the same week? ISPE's Orchestrating Asset Intelligence webinar runs a week earlier, and the full events directory lists everything we have verified.

Frequently asked questions

When is the FDA Pediatric Advisory Committee meeting?

16 September 2026, 10:00 a.m. to 4:00 p.m. Eastern Time, held virtually and open to the public, per the FDA's Federal Register notice (docket FDA-2026-N-7514, published 28 July 2026).

How do I attend or watch the meeting?

The meeting is conducted via online teleconferencing/video conferencing, with participants heard, viewed, captioned and recorded. Access details are published on the meeting's Federal Register notice and FDA's advisory committee calendar.

What does the Pediatric Advisory Committee do?

It provides advice and recommendations to FDA on pediatric regulatory issues, including drug and device safety and use in children.

Is there a fee to attend?

No fee is stated; the meeting is open to the public at no cost, consistent with FDA advisory committee meetings generally.

Sources & further reading

  1. Federal Register / FDA. Pediatric Advisory Committee (PAC); Notice of Meeting; Establishment of a Public Docket; Request for Comments, 07/28/2026. federalregister.gov
  2. FDA. Pediatric Advisory Committee (PAC) — committee home. fda.gov

Event details are published by the organizer and can change. This listing was verified via WebSearch corroboration of the Federal Register notice's own text rather than a direct fetch, because this session's network egress could not reach federalregister.gov or fda.gov directly — confirm dates and access on the notice itself before making plans. Last verified 31 July 2026.